Pendal Group’s ICU Medical ICUI Stock Holding History

Pendal Group’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,814	Closed	-$703K	–	470
2020 Q2	$703K	Buy	+3,814	New	+$758K	0.01%	277

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FPP

Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return

Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Pendal Group's ICUI Position: Q3 2020 in Review

Pendal Group sold out of ICU Medical (ICUI) in Q3 2020, closing a stake of 3,814 shares — an estimated $703K sold.

Pendal Group first reported a position in ICUI in Q2 2020 and held it in 1 quarter. The position peaked at $703K in Q2 2020. 283 funds tracked by Wall St. Rank hold ICUI as of Q3 2020.

Pendal Group reported no remaining ICU Medical position as of Q3 2020 after selling out during the quarter.
Pendal Group sold 3,814 ICU Medical shares in Q3 2020, an estimated $703K.
Pendal Group first reported a position in ICU Medical in Q2 2020 and held it in 1 quarter.
Pendal Group's ICU Medical position peaked at $703K in Q2 2020.
283 funds tracked by Wall St. Rank held ICU Medical as of Q3 2020.

Based on Pendal Group's 13F filing for Q3 2020, filed 2 Nov 2020.